Form D · Other Technology

Thynk Health, LLC

Lexington, KY · CIK 0001894946

Offering snapshot reported Oct 30, 2023 · SEC filing

Reported sold
$70K
Offering amount: $1.75M
Investors reported
1
Form D · investor count
Minimum accepted
$30K
Reported outside-investor minimum
First sale
Sep 28, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 30, 2023Initial$70,000No comparison1SEC filing
Aug 16, 2022Initial$100,000No comparison1SEC filing
Apr 28, 2022Amendment$220,000$0vs Dec 1, 202111SEC filing
Dec 1, 2021Initial$220,000No comparison5SEC filing
Nov 30, 2021Initial$1,075,990No comparison21SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-495891
Sales Commission Cash placement fee paid 7% of the gross proceeds received by the Company for this offering

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Phillip Nash Roberts6182908Carofin, LLC · CRD 298717

Source: Form D, filed Oct 30, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joey Bargo Director
Steven Brock Director
Todd Clark Director
Kevin Croce Director
Brian Luftman Director
Jeffrey Timbrook Executive
Daniel Weeks Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
110 W. Vine St., Ste 300
Lexington, KY, 40507